Comparison
1p35 2 Microdeletion Syndrome vs 14q11 2 Microduplication Syndrome C4749855
Clinical comparison between 1p35 2 Microdeletion Syndrome and 14q11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
6 comparison axes
Onset
1p35 2 Microdeletion Syndrome
0-null
14q11 2 Microduplication Syndrome C4749855
0-5
Onset patterns differ
Severity
1p35 2 Microdeletion Syndrome
severe
14q11 2 Microduplication Syndrome C4749855
moderate
Different severity levels
Chronic
1p35 2 Microdeletion Syndrome
Chronic
14q11 2 Microduplication Syndrome C4749855
Chronic
Differing course
Communicable
1p35 2 Microdeletion Syndrome
No
14q11 2 Microduplication Syndrome C4749855
No
Different transmission
Body System
1p35 2 Microdeletion Syndrome
congenital
14q11 2 Microduplication Syndrome C4749855
congenital
Same/different system
Category
1p35 2 Microdeletion Syndrome
rare-disease
14q11 2 Microduplication Syndrome C4749855
genetic
Different category
Bottom line
1p35-2-microdeletion-syndrome-C5679992 and 14q11-2-microduplication-syndrome-C4749855 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1p35 2 Microdeletion Syndrome | 14q11 2 Microduplication Syndrome C4749855 | Discriminating power |
|---|---|---|---|
| Developmental delay | Not established in the supplied source; delay may occur but is not confirmed here. | Source notes variable features that may include developmental delay. | Low |
| Reported severity | Axis lists severe, but no supporting clinical description is supplied. | Axis lists moderate, with variable presentation. | Moderate |
| Chromosomal change | Missing material at 1p35.2, if confirmed by testing. | Extra material at 14q11.2, if confirmed by testing. | High |
When to favor each condition
Choose 1p35 2 Microdeletion Syndrome when
A confirmed deletion involving 1p35.2
The genomic location and loss of material distinguish this finding.
High
Phenotype appears more severe than the comparison source
Severity is listed as severe, but this is not independently established.
Low
Family or clinician seeks deletion-specific counseling
Counseling should address a deletion rather than a duplication.
Moderate
Choose 14q11 2 Microduplication Syndrome C4749855 when
A confirmed duplication at 14q11.2
The genomic location and extra material distinguish this finding.
High
Variable congenital features with possible developmental delay
This matches the limited supplied description, without proving the diagnosis alone.
Moderate
Supportive monitoring is the stated management focus
The source emphasizes supportive care rather than a specific treatment.
Moderate
How key tests differ
| Test | 1p35 2 Microdeletion Syndrome | 14q11 2 Microduplication Syndrome C4749855 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show a deletion at 1p35.2. | May show a duplication at 14q11.2. | The copy-number result, not symptoms alone, separates the findings. |
| Confirmatory cytogenetic testing | May clarify deletion size and boundaries when needed. | May clarify duplication size and boundaries when needed. | Confirmation and interpretation belong to a genetics clinician. |
| Developmental assessment | No specific pattern is established by the source. | May identify delay, but findings can vary. | Assessment supports care planning and does not replace genomic testing. |
Prognosis comparison
1p35 2 Microdeletion Syndrome
- Outcome
- Outcome is not established from the supplied data.
- Factors
- Reported severe axis, confirmed genomic result, and actual clinical findings may matter.
14q11 2 Microduplication Syndrome C4749855
- Outcome
- Variable course; supportive care and monitoring are emphasized.
- Factors
- Degree of developmental delay, associated findings, and individual support needs.
Time frame: Congenital and chronic; no reliable timeline is supplied.
Prognosis should be individualized; no mortality or prevalence figures are established here.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental difficulty | Possible but not established in the supplied data. May occur and can vary in degree. Early developmental surveillance is reasonable; exact complications are not defined here. |
| Associated congenital anomalies | Not specified by the source. Features may vary; no specific anomaly list is supplied. Do not infer organ involvement without clinical evaluation. |
| Long-term support needs | Potentially substantial if severity is truly severe, but evidence is limited. Supportive therapies and monitoring are described. Needs should be individualized rather than predicted from the label alone. |
Patient education highlights
- HighTest versus diagnosis
A chromosomal finding requires clinical correlation and does not by itself establish every symptom or prognosis.
- HighGenetics review
Ask a genetics clinician to explain the result, possible inheritance, and whether family testing is appropriate.
- MediumSupportive care
Care commonly focuses on developmental monitoring and therapies tailored to observed needs.